Eli Lilly to Invest $5 Billion in New Virginia Drug Manufacturing Plant

Core Viewpoint - The company is committed to enhancing its domestic medicine production by establishing four new pharmaceutical manufacturing sites [1] Group 1 - The plan is part of the drugmaker's broader strategy to strengthen its manufacturing capabilities within the domestic market [1]